相关实验视频

Updated: Jun 24, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

类似收费受体7/8激动剂的分子工程策略,旨在增强免疫刺激激活的作用

Liuwei Gu¹, Xiaojie Kong¹, Mengyan Li¹

¹Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. gli@ntu.edu.cn.

Chemical communications (Cambridge, England)

|May 7, 2024

概括

托尔类受体7/8 (TLR-7/8) 激动剂通过激活天生的免疫力,在癌症免疫治疗中显示出有前途. 研究纳米医学策略,以控制TLR-7/8激动剂的输送,最大限度地减少不良事件和增强抗瘤免疫反应.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
纳米医学是一种纳米医学.

背景情况:

托尔类受体7/8 (TLR-7/8) 激动剂是先天免疫反应的强有力的激活剂,这使得它们在癌症免疫治疗中具有价值.
没有控制的TLR-7/8激动剂可以导致严重的免疫相关不良事件 (irAEs).
需要设计出能够对瘤微环境做出反应的TLR-7/8激动剂,以实现向免疫激活.

研究的目的:

为癌症免疫治疗中TLR-7/8激动剂的进展提供全面的概述.
阐明TLR-7/8激动剂的机制及其潜在的临床应用.
探索纳米医学策略,以提高TLR-7/8激动剂的疗效和安全性.

主要方法:

对癌症免疫治疗中TLR-7/8激动剂的当前文献的综述.
对纳米医学方法进行分析,以对TLR-7/8激动剂的向输送和受控释放进行分析.
讨论工程TLR-7/8激动剂对瘤微环境有反应的策略.

主要成果:

TLR-7/8激动剂有效地刺激先天免疫力,为癌症治疗提供了一个有前途的途径.
纳米医学提供了通过控制它们的管理和减少irAEs来改善TLR-7/8激动剂的治疗指数的策略.
工程 TLR-7/8 激动剂可以被设计为响应特定的瘤微环境线索,增强向免疫激活.

结论:

在TLR-7/8激动剂方面的进展,特别是通过纳米医学,具有改善癌症免疫治疗的巨大潜力.
对TLR-7/8激动剂的战略设计对于最大限度地提高抗瘤免疫反应,同时最大限度地减少不良事件至关重要.
对工程TLR-7/8激动剂及其临床转化进行进一步的研究是有必要的,以克服癌症免疫疗法的当前挑战.

更多相关视频

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

相关概念视频

Signal Transduction: Overview

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...